C

Chengdu Bright Eye Hospital Co Ltd
SZSE:301239

Watchlist Manager
Chengdu Bright Eye Hospital Co Ltd
SZSE:301239
Watchlist
Price: 47.6 CNY -2.4% Market Closed
Market Cap: 7.1B CNY
Have any thoughts about
Chengdu Bright Eye Hospital Co Ltd?
Write Note

Net Margin
Chengdu Bright Eye Hospital Co Ltd

2.8%
Current
6%
Average
2.2%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
2.8%
=
Net Income
76.4m
/
Revenue
2.8B

Net Margin Across Competitors

Country CN
Market Cap 7.1B CNY
Net Margin
3%
Country US
Market Cap 78.4B USD
Net Margin
9%
Country SA
Market Cap 98B SAR
Net Margin
21%
Country ZA
Market Cap 24.2B Zac
Net Margin
19%
Country ZA
Market Cap 20B Zac
Net Margin
6%
Country CN
Market Cap 131.1B CNY
Net Margin
18%
Country MY
Market Cap 62B MYR
Net Margin
11%
Country IN
Market Cap 1.1T INR
Net Margin
19%
Country US
Market Cap 12.3B USD
Net Margin
15%
Country IN
Market Cap 1T INR
Net Margin
5%
Country US
Market Cap 11.9B USD
Net Margin
7%
No Stocks Found

Chengdu Bright Eye Hospital Co Ltd
Glance View

Market Cap
7.1B CNY
Industry
Health Care

Chengdu Bright Eye Hospital Co Ltd. emerged as a beacon in the healthcare sector, nestled in the bustling city of Chengdu, China. The company carved its niche by focusing on a clear vision—literally and figuratively—through specializing in ophthalmic services. This focus on eye health is not only crucial in a densely populated region but also timely, as urban lifestyles contribute to rising eye health issues. With a commitment to offering comprehensive eye care, the hospital provides a range of services from basic eye examinations and common procedures like cataract surgeries, to advanced treatments involving laser technologies. This broad spectrum of services addresses the varied needs of patients, ensuring a continuous flow of clients from consultations to complex surgical interventions. The hospital operates in a competitive market but distinguishes itself by leveraging modern technology and an emphasis on patient-centric care. Its financial model is built around both volume and specialization, attracting patients through quality and trust. Revenue flows from direct payments for services rendered and strategic alliances with insurance companies that subsidize eye care treatments. Additionally, the hospital invests in community outreach and education, raising awareness about eye health and driving traffic to its facilities. Through a combination of strategic location, a diversified service portfolio, and a reputation for medical excellence, Chengdu Bright Eye Hospital not only captures a significant share of the regional eye care market but also sets a precedent for service-driven profitability in the healthcare sector.

Intrinsic Value
79 CNY
Undervaluation 40%
Intrinsic Value
Price
C

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
2.8%
=
Net Income
76.4m
/
Revenue
2.8B
What is the Net Margin of Chengdu Bright Eye Hospital Co Ltd?

Based on Chengdu Bright Eye Hospital Co Ltd's most recent financial statements, the company has Net Margin of 2.8%.